false
0001847367
0001847367
2025-07-30
2025-07-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 30, 2025
Alumis Inc.
(Exact name of Registrant as Specified in Its
Charter)
Delaware |
|
001-42143 |
|
86-1771129 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File
Number) |
|
(IRS Employer
Identification No.) |
280 East Grand Avenue
South San Francisco, California 94080
(Address of Principal Executive Offices)
Registrants Telephone Number, Including Area Code: (650) 231-6625
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instructions A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, $0.0001 par value per share |
|
ALMS |
|
The Nasdaq Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On July 30, 2025, Alumis Inc. (the “Company”) held its
2025 Annual Meeting of Stockholders (the “Annual Meeting”). As of June 4, 2025, the record date for the Annual Meeting, 96,004,357
shares of voting common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders
at the Annual Meeting is set forth below. A more complete description of each matter can be found in the Company’s definitive proxy
statement filed with the U.S. Securities and Exchange Commission on June 16, 2025.
Proposal 1: Election of Directors
Srinivas Akkaraju, M.D., Ph.D. and Sapna Srivastava,
Ph.D. were elected as a Class I directors, to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly
elected and qualified, or until their earlier death, resignation or removal. The final voting results are as follows:
Name of Director Elected |
|
Votes For |
|
Votes Withheld |
|
Broker Non-Votes |
Srinivas Akkaraju, M.D., Ph.D. |
|
55,095,965 |
|
7,723,141 |
|
16,380,181 |
Sapna Srivastava, Ph.D. |
|
54,546,203 |
|
8,272,903 |
|
16,380,181 |
Proposal 2: Ratification of Appointment of
the Company’s Independent Registered Public Accounting Firm
The Company’s stockholders ratified the
appointment by the Audit Committee of the Company’s Board of Directors of PricewaterhouseCoopers LLP as the Company’s independent
registered public accounting firm for the fiscal year ending December 31, 2025. The final voting results are as follows:
Votes For |
|
Votes Against |
|
Abstentions |
78,973,998 |
|
84,524 |
|
140,765 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Alumis Inc. |
|
|
Date: August 4, 2025 |
By: |
/s/ Martin Babler |
|
|
Martin Babler |
|
|
President & Chief Executive Officer |